Клинические рекомендации по диагностике глобальной задержки развития и умственной отсталости Американской академии неврологии и Американской академии педиатрии в своих рекомендациях 2006 года не рекомендовали систематическое проведение метаболических исследований у детей с глобальной задержкой развития, поскольку их диагностическая эффективность составляла 1-5%. Однако в обзоре 2014 года эта рекомендация была изменена, и метаболическое исследование было включено у детей без установленной причины в соответствии с протоколом, предложенным ван Карнебеком и состоящим из двух этапов:

1-й этап: Нецелевой метаболический скрининг.
  • Кровь:
    • Лактат.
    • Аммоний.
    • Аминокислоты.
    • Фолат.
    • Сиалотрансферрины.
    • Медь и целлюлоплазмин.
    • Общий гомоцистеин.
    • Ацилкарнитины.
    • VLCFA.
  • Моча:
    • Органические кислоты.
    • Креатин и ГАА.
    • Глюкозамингликаны.
    • Олигосахариды.
2-й этап: Целевой метаболический скрининг.

No obstante, también puede orientarse a qué pacientes realizar un estudio metabólico a partir de la presencia de determinados datos de la historia clínica o características exploratorias que incrementan la probabilidad de una metabolopatía (¿cuando sospechar una metabolopatía?).

В сети Излечимый идентификатор puede buscarse información para orientar de forma más adecuada el estudio apropiado.

В сети Vademecum Metabólicum, existe un compendio de acceso libre sobre todos los errores congénitos del metabolismo.

19955111 {19955111:5WUGPWQ8} 1 Ванкувер 50 по умолчанию 944 https://neuropediatoolkit.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%225WUGPWQ8%22%2C%22library%22%3A%7B%22id%22%3A19955111%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Moeschler%20et%20al.%22%2C%22parsedDate%22%3A%222014-09-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%20style%3D%26quot%3Bclear%3A%20left%3B%20%26quot%3B%26gt%3B%5Cn%20%20%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-left-margin%26quot%3B%20style%3D%26quot%3Bfloat%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%26quot%3B%26gt%3B1.%26lt%3B%5C%2Fdiv%26gt%3B%26lt%3Bdiv%20class%3D%26quot%3Bcsl-right-inline%26quot%3B%20style%3D%26quot%3Bmargin%3A%200%20.4em%200%201.5em%3B%26quot%3B%26gt%3BMoeschler%20JB%2C%20Shevell%20M%2C%20Moeschler%20JB%2C%20Shevell%20M%2C%20Saul%20RA%2C%20Chen%20E%2C%20et%20al.%20Comprehensive%20Evaluation%20of%20the%20Child%20With%20Intellectual%20Disability%20or%20Global%20Developmental%20Delays.%20Pediatrics%20%5BInternet%5D.%202014%20Sept%201%20%5Bcited%202015%20June%2029%5D%3B134%283%29%3Ae903%26%23x2013%3B18.%20Available%20from%3A%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fpediatrics.aappublications.org%5C%2Fcontent%5C%2F134%5C%2F3%5C%2Fe903%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fpediatrics.aappublications.org%5C%2Fcontent%5C%2F134%5C%2F3%5C%2Fe903%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%20%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Comprehensive%20Evaluation%20of%20the%20Child%20With%20Intellectual%20Disability%20or%20Global%20Developmental%20Delays%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20B.%22%2C%22lastName%22%3A%22Moeschler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Shevell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20B.%22%2C%22lastName%22%3A%22Moeschler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Shevell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20A.%22%2C%22lastName%22%3A%22Saul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emily%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Debra%20L.%22%2C%22lastName%22%3A%22Freedenberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rizwan%22%2C%22lastName%22%3A%22Hamid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marilyn%20C.%22%2C%22lastName%22%3A%22Jones%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joan%20M.%22%2C%22lastName%22%3A%22Stoler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beth%20Anne%22%2C%22lastName%22%3A%22Tarini%22%7D%5D%2C%22abstractNote%22%3A%22Global%20developmental%20delay%20and%20intellectual%20disability%20are%20relatively%20common%20pediatric%20conditions.%20This%20report%20describes%20the%20recommended%20clinical%20genetics%20diagnostic%20approach.%20The%20report%20is%20based%20on%20a%20review%20of%20published%20reports%2C%20most%20consisting%20of%20medium%20to%20large%20case%20series%20of%20diagnostic%20tests%20used%2C%20and%20the%20proportion%20of%20those%20that%20led%20to%20a%20diagnosis%20in%20such%20patients.%20Chromosome%20microarray%20is%20designated%20as%20a%20first-line%20test%20and%20replaces%20the%20standard%20karyotype%20and%20fluorescent%20in%20situ%20hybridization%20subtelomere%20tests%20for%20the%20child%20with%20intellectual%20disability%20of%20unknown%20etiology.%20Fragile%20X%20testing%20remains%20an%20important%20first-line%20test.%20The%20importance%20of%20considering%20testing%20for%20inborn%20errors%20of%20metabolism%20in%20this%20population%20is%20supported%20by%20a%20recent%20systematic%20review%20of%20the%20literature%20and%20several%20case%20series%20recently%20published.%20The%20role%20of%20brain%20MRI%20remains%20important%20in%20certain%20patients.%20There%20is%20also%20a%20discussion%20of%20the%20emerging%20literature%20on%20the%20use%20of%20whole-exome%20sequencing%20as%20a%20diagnostic%20test%20in%20this%20population.%20Finally%2C%20the%20importance%20of%20intentional%20comanagement%20among%20families%2C%20the%20medical%20home%2C%20and%20the%20clinical%20genetics%20specialty%20clinic%20is%20discussed.%22%2C%22date%22%3A%2209%5C%2F01%5C%2F2014%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1542%5C%2Fpeds.2014-1839%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fpediatrics.aappublications.org%5C%2Fcontent%5C%2F134%5C%2F3%5C%2Fe903%22%2C%22PMID%22%3A%2225157020%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220031-4005%2C%201098-4275%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22TSGGWJ4V%22%2C%22WP7IK3VM%22%5D%2C%22dateModified%22%3A%222026-07-15T22%3A40%3A32Z%22%7D%7D%5D%7D
1.
Moeschler JB, Shevell M, Moeschler JB, Shevell M, Saul RA, Chen E, et al. Comprehensive Evaluation of the Child With Intellectual Disability or Global Developmental Delays. Pediatrics [Internet]. 2014 Sept 1 [cited 2015 June 29];134(3):e903–18. Available from: http://pediatrics.aappublications.org/content/134/3/e903